Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hi guys. Just send my previous e-mail to Jonathan. I think it would be nice for you guys to send him congrats notes, to say something good and encouraging to him. At least for people to whom he responded with his e-mails. May be somebody with better english than mine could get us all sign it.
CONGRATS TO ALL OF US!!! Today is very important milestone in Medify's run. And don't be afraid of competition. Every time I read the word "remote" in reference to UK and Europe I feel great. It means that our time is coming and our time is now.
GO JOHNY GO!!!
But ours is the only "delighted" system available:
"Jeremy Nettle, EMEA Business Development Director for healthcare at Oracle, said: "We are excited at the potential for Medify's technology and are delighted to welcome Medify as an Oracle UK partner company. IT is an important enabler of change and system transformation in the NHS."
From the same source on 03/05/05.
Doc, G.. bless you anf your family and the best wishes!!!
We have the best team here!!!
GO JOHNY GO!!!
Doc, come on, be nice.
My brocker knows nothing about dividend. Can anyone provide contact information and ratio being paid? Thank you.
Herbie, as you said:
On 8/14/06:
"Well I'm nibbling at between 0.085 and 0.09. I have a lot of shares already, and I have made a very conscious decision to not buy anymore above 0.09, regardless of how it looks."
On 8/15/06:
"Bottom line, one either has faith in the company or one doesnt. If one does, buy the shares. If one don't, don't buy the shares..."
We all say things like these and the reason is:
Clancy today:
"Using words like "soon" and "slight delay" does NOT constitute a communication plan."
bur creates uncertainty which is not a good feeling.
What creates a good feeling for me is Lem's Oracle post. This is one of the main reasons I'm here too, Lem, with nice picture of Oracle. That view I see every day when I go for a walk and it gives me more assurance and sense of reality.
Bottom line:
Jonathan, we believe in you and trust you with our hard working money. This is all that I want you to know.
GO JONATHAN GO!!!
Where did you get this number? Please be specific.
My brocker knows nothing about dividend. Can anyone provide contact information and ratio being paid? Thank you.
And now let's have news brake at Medify music station:
there are no big news yet, it's all quet on Medify front.
Back to pinkie music station.
Doc, this how I feel about Medify at this point:
Hi Jonathan,
Congratulations on filing complete QR and on time!
Even with developments have being at some slow pace they do show definite progress and positive restructure. I look into co's future with more confidence and with great expectations.
My best wishes to you and company.
Solidgold,
One of your biggest investors and full supporters.
Doc, if you talking so much lately, would be nice to hear your encouraging thougts about Medify. Thanks.
No way! YOU ARE INCLUDED!!!
Always for full nudity! Go TORONTO GO GIRLS!
Have a good night my foreign freinds too or good morning!
Just watching 49s and Alex Smith kicking Bears in the rear and drinking some Californian red Zinfandel and Chardonnay. Life is beautiful. God bless America!!! Have a good night my friends.
Looks like a good news to me. Sorry Herbie. I got my last @6c.
I like you all guys and look forward to drinking with all of you together at some happier time.
So, not much faith in Jonathan paying? Thanks Lem.
Here is my new favorite song:
http://www.shinesforall.com/archives/2006/07/israels_send_me.html
Lem, got your message. What can I say? GO JONATHAN GO!!!
By the way, I'm not a drinker but can drink everything ... if Jonathan pays.
Have to disagree on this with you. Trevor was not just an employee. He was one of 2 guys from foundation of this company.
It is a mojor development and should have some reasons also a material fact. I don't want the details, but to be totally silent about it doesn't speak good about comapny in my book.
On a positive note:
1. Was talking to Trevor about interviews long before so we finally got one.
2. QR ON TIME!!!
3.2500 could be the start for global medification.
4.Dividends are not dead yet.
5.Over all feel more organization.
6.Still a believer.
7.GO JONATHAN GOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO!!!!!!!!
Lem, it could be my mistake, sorry. Very disappointed, but not surprised. And the last one is even worst.
Clancy, agree with your 1st point.
As far as 2nd "have to learn to walk 1st." Should be at $5 by the end of last year according to some projections.
Getting tired of global potentials. Just want some freeking income. What happened with all these numerous pilots?
C- for interview and D+ for QR.
Clancy, I always like the way you summarizing stuff.
You pretty much said it all again. As far as the "actial meat" it was not any. Whom do they think we are?
If one compares previous QRs with present than he/she will notice complete disappearance of quite a few projects being mentioned before.
Also, complete secrecy about 2 KEY PLAYERS LEFT and the reasons for it, only adjustments in number of restricted shares.
As far as any projections so it's a laughable matter at this point.
Overall, big disapointment and low PPS.
The interview was nothing new but an event by itself.
And we all will sing OUR SONG!
Lem, you should e-mail this song to Jonathan and it should become his morning anthem.
Interesting:
EU project looks at DNA link to patient records
09 Aug 2006
A telemedicine project funded by the European Union has been looking at ways of matching patients in emergency situations with their electronic records using their DNA.
The DICOEMS project was set up to help integrate healthcare databases through means of a grid system, with a view to making more information available for paramedics and in accident and emergency departments.
One of the data sources looked at by the programme was a database linking patients to their DNA. DICOEMS attempted to create a device to analyse the DNA of a patient's blood and match it to a record containing their medical history, but this was not successful.
"Unfortunately, the European Union does not yet have a legal framework allowing collection of an extensive DNA database from the general public," Matteo Colombo, head, technical specialist at partner and technology company Synergia 2000, told journal IST Results.
"That lack made this goal unworkable. This turned out to be the project's biggest obstacle."
The project did have several successes in linking databases to help emergency care, however. For instance, a text-search tool was used by emergency switchboard operators that matched clinical needs with the most appropriate hospital to treat the patient, and a patient's GP or carer could even patch into the network and remotely participate in treatment.
Colombo added that the work in the field of DNA testing was still valuable as the technology could be used to identify smaller sets of people, such as members of the police or fire service: "Privacy concerns might be less of an issue, because the organisation would manage its own database, which could be used for identifying injured or dead policemen or firemen, for example."
Tests were done of the network in Italy, with work on integration of databases carried out in Guy's and St Thomas Hospital NHS Trust, London. The database integration technology will be introduced in the Italian emergency services at the end of the year, pending approval by the relevant authorities.
Colombo added: "We hope to arrange an agreement allowing Guy's and St Thomas Hospital to serve as the bridge between the DICOEMS Italian organisation and the UK's entire NHS system."
The project's main aim was to improve data sharing across organisations. "The system will improve decision support, diagnosis and risk management in critical situations occurring far from hospital emergency rooms," said Colombo.
DICOEMS was funded by a grant from the Specific Targeted Research Projects (STREP) scheme, part of the EU's FP6 research programme.
Links
DICOEMS
© 2005 E-HEALTH-MEDIA LTD. ALL RIGHTS RESERVED.
Abscence of real PR.
I think MMs will try to show activity till the end of the day.
In fact it's all far from it.
We are still @ 7c.
21...sounds like terrorism to me
Also, much nicer looking web site, secrecy with sudden departure of 2 key guys, dividends game and ... delighted Jonathan - all of these could be some very good signs. IMHO
Well said. GO JONATHAN GO!!!
What makes this board special is that most of us invested in this company from the 1st day. We put huge amount of money into this because we followed PRs and we believed. And we still do, this is why Jonathan and company is obligated to respond to us, to give us truthfull information to the best of his abilities and to keep us informed. There are more of us at this board than at others with respect to them.
I'm trying to confirm with Jonathan too for some special people here, but it would be nice if Jonathan would make it public.
Mfysinterest, why are you so negative to everyone on this board?
$1 by tomorrow.
You guys want too much. You got announcement, you got access cod and now you want the actial inteview too? You are spoild!!!
Yep, spoild by Medify!!!
At least a posting about interview. Don't have much to say yet anyway. GO JONATHAN GO!!!